ESR1 and breast cancer: Progesterone signaling pathway (MPRPATHWAY) is increased and ER transcriptional activity is enhanced according to motif analysis confirming that elevated sex-hormone load may lead to worse prognosis of breast cancer patients, which is supported by the widely use and benefit of anti-hormonal treatment of breast cancers retaining hormone receptors.